Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.

Clinical trial NCT02718391 · TERMINATED

Trial details

NCT number: NCT02718391
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma Adjuvant Drug Therapy Vaccin Therapy

Start date: 2015-08-01
Primary completion: 2019-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.